ES2040294T3 - Nuevos compuestos de azufre, procedimientos para su preparacion, asi como medicamentos. - Google Patents

Nuevos compuestos de azufre, procedimientos para su preparacion, asi como medicamentos.

Info

Publication number
ES2040294T3
ES2040294T3 ES198888111808T ES88111808T ES2040294T3 ES 2040294 T3 ES2040294 T3 ES 2040294T3 ES 198888111808 T ES198888111808 T ES 198888111808T ES 88111808 T ES88111808 T ES 88111808T ES 2040294 T3 ES2040294 T3 ES 2040294T3
Authority
ES
Spain
Prior art keywords
denotes
alkyl
radical
group
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888111808T
Other languages
English (en)
Inventor
Erhard Dr. Reinholz
Ernst-Christian Dr.Rer.Nat. Witte
Liesel Dr.Med. Doerge
Johannes Dr.Dr.Arzt. Pill
Karlheinz Dr.Rer.Nat. Stegmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2040294T3 publication Critical patent/ES2040294T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/16—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Eye Examination Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)

Abstract

COMBINACIONES DE LA FORMULA(I) DONDE R1 REPRESENTA GRUPOS ALCINICOS O ALCENILICOS MENORES, UN RESTO CICLOALCILICO, UN EVENTUALMENTE RESTO ARALCILICO, ARALCENILICO O ARILICO. M REPRESENTA LAS CIFRAS 0, 1 O 2 B REPRESENTA UNA CADENA ALCILICA SATURADA, LINEAR O RAMIFICADA CON UN MAXIMO DE 6 C - ATOMOS. W REPRESENTA 1.2-, 1.3- O 1.4- FENILO A REPRESENTA UN GRUPO C1 - C6 - O C2 - C6 - ALCILICO, UN GRUPO FORMIL - C1 - C5 - ALCILICO, UN GRUPO HIDROXI - CO - C6 ALCILICO, UN GRUPO CARBOXI - CO - C5 - ALCILICO, UN RESTO DE ACIDO OXIACETICO O UN RETO D - R2 DONDE D REPRESENTA UN GRUPO - C - O - CH - Y I I O OH R2 REPRESENTA HIDROGENO, UN RESTO C1 - C5 ALCILICO, HIDROXI - C1 - C5 - ALCILICO O UN CARBOXI - CO - C4 - ALCILICO. ASI COMO CUYAS SALES, ESTER Y AMIDOS SOPORTABLE EN FARMACIA. METODO PARA SU FABRICACION Y LA DE MEDICAMENTOS CONTENIENDO ESTAS COMBINACIONES, PARA EL TRATAMIENTO DE LAS ENFERMEDADES METABOLICAS EL ASMA O LOS PROBLEMAS DE CIRCULACION.
ES198888111808T 1987-07-28 1988-07-22 Nuevos compuestos de azufre, procedimientos para su preparacion, asi como medicamentos. Expired - Lifetime ES2040294T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873724923 DE3724923A1 (de) 1987-07-28 1987-07-28 Neue schwefelverbindungen, verfahren zu ihrer herstellung sowie arzneimittel

Publications (1)

Publication Number Publication Date
ES2040294T3 true ES2040294T3 (es) 1993-10-16

Family

ID=6332503

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888111808T Expired - Lifetime ES2040294T3 (es) 1987-07-28 1988-07-22 Nuevos compuestos de azufre, procedimientos para su preparacion, asi como medicamentos.

Country Status (14)

Country Link
EP (1) EP0301421B1 (es)
JP (1) JPS6447758A (es)
KR (1) KR890001969A (es)
AT (1) ATE66672T1 (es)
AU (1) AU2015088A (es)
DD (1) DD285976A5 (es)
DE (2) DE3724923A1 (es)
DK (1) DK423188A (es)
ES (1) ES2040294T3 (es)
FI (1) FI883538A (es)
HU (1) HU199408B (es)
IL (1) IL87176A0 (es)
PT (1) PT88095B (es)
ZA (1) ZA885474B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070099A (en) * 1988-10-31 1991-12-03 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same method of use
US5006542A (en) * 1988-10-31 1991-04-09 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same and method of use
GB8921221D0 (en) * 1989-09-20 1989-11-08 Ici Plc Compound,preparation and use
JP3712208B2 (ja) 1993-06-25 2005-11-02 メレルファーマスーティカルズ インコーポレイテッド 抗ヒスタミン性の４−ジフェニルメチル／ジフェニルメトキシピペリジン誘導体類を製造する新規な中間体
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
US6683094B2 (en) 1998-07-02 2004-01-27 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6700012B2 (en) 1998-07-02 2004-03-02 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
TW200904329A (en) * 2007-05-18 2009-02-01 Sumitomo Chemical Co Organic sulfur compound and its use for controlling harmful arthropod
KR101814679B1 (ko) 2015-08-28 2018-01-03 신성금형 주식회사 전기매트용 전원 커넥터

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB790199A (en) * 1954-02-18 1958-02-05 Boots Pure Drug Co Ltd Benzyl phenyl sulphides and acaricidal compositions thereof
GB780520A (en) * 1955-03-11 1957-08-07 Boots Pure Drug Co Ltd New sulphur containing compounds
US4752616A (en) * 1987-06-29 1988-06-21 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, compositions containing same and method of use

Also Published As

Publication number Publication date
HUT47901A (en) 1989-04-28
ZA885474B (en) 1989-04-26
ATE66672T1 (de) 1991-09-15
EP0301421A3 (en) 1989-05-10
DK423188A (da) 1989-01-29
AU2015088A (en) 1989-02-02
PT88095B (pt) 1995-03-01
IL87176A0 (en) 1988-12-30
EP0301421B1 (de) 1991-08-28
FI883538A (fi) 1989-01-29
KR890001969A (ko) 1989-04-07
FI883538A0 (fi) 1988-07-27
PT88095A (pt) 1989-06-30
DE3724923A1 (de) 1989-02-09
DK423188D0 (da) 1988-07-28
DE3864474D1 (de) 1991-10-02
JPS6447758A (en) 1989-02-22
HU199408B (en) 1990-02-28
EP0301421A2 (de) 1989-02-01
DD285976A5 (de) 1991-01-10

Similar Documents

Publication Publication Date Title
KR890011601A (ko) (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약
ATE89263T1 (de) Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PT82826B (pt) Processo para a preparacao de conjugados de substancia activa composto ligado fixamente a uma membrana
HUT51250A (en) Process for production of derivatives of sulfhonamid and medical compositions containing them
FI823274L (fi) Laekemedel, daeri innehaollna vicinala dihydroxialkylxantiner, framstaellningsfoerfaranden foer desxantinfoereningar och foer dessa laempade mellanprodukter
ES2040294T3 (es) Nuevos compuestos de azufre, procedimientos para su preparacion, asi como medicamentos.
ES2126581T3 (es) Derivados de 3-(piperazino-alquil)indol condensados en posiciones 1,7, asi como procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.
IL95498A0 (en) Phospholipid derivatives as antiviral pharmaceuticals and phospholipids
ATE14424T1 (de) Imidazolidin-derivate, verfahren zu deren herstellung und therapeutische anwendung.
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.
GB2014995A (en) (Cycloalkyl)-alkylbenzamides
DE3776171D1 (de) 1-styrensulfonyl-2-oxo-5-hydroxy-pyrrolidine, ihre vorprodukte und verfahren zur herstellung, sie enthaltende zusammensetzungen und ihre anwendung als heilmittel.
ES530729A0 (es) Procedimiento para la obtencion de esteres de acido fosfonico
ATE6063T1 (de) Cycloalkano-thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
ATE25584T1 (de) Verwendung von gamma-piperidino-butyrophenonen zu herstellung von arzneimitteln zum behandeln von diarrhoee.
FI824061L (fi) Foerfarande foer framstaellning av nya 3'''-dehydro-kardenolid-tridigitoxosidoximer och anvaendningdem som laekemedel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 301421

Country of ref document: ES